Although the link between GBA1 pathogenic variants and PD is well established, and a growing number of carriers are being detected through prenatal carrier screening programs, discussion of the risk of the fetus developing PD and preventive options is not part of common practice. Here, GBA1 is linked to Parkinson disease.